What different studies actually measured
- Research question
- Diarrhea during antibiotic use across trials
- What researchers found
- A 2015 meta-analysis found fewer episodes across pooled child and adult trials.
- What limits the finding
- The trials used their own diarrhea definitions. The average does not establish a predictable benefit for every product or person.See reference 2
- Research question
- Adults taking antibiotics in hospital
- What researchers found
- A 477-person randomized trial found no clear benefit. A 2026 trial of 100 adults at one hospital reported fewer episodes with the freeze-dried preparation it tested.
- What limits the finding
- The newer trial followed people for 28 days and counted at least two loose stools in 24 hours. The unusually high placebo event rate and different definitions limit comparisons.See reference 3,See reference 4
- Research question
- Prevention of C. difficile infection
- What researchers found
- Professional guidance differs. AGA made a conditional suggestion for selected formulations, including this yeast. ACG recommended against routine probiotic use for primary prevention in people taking antibiotics.
- What limits the finding
- Diarrhea and laboratory-confirmed infection are different outcomes. No C. difficile infection events occurred in either arm of the newer trial.See reference 4,See reference 5,See reference 6
Read the yeast and strain information
Start with the full organism name, then look for a strain code, a stated live count and any storage instructions. Colony-forming units (CFU) describe the number of viable microorganisms measured under defined conditions. A brand or a larger combined CFU count for a blend does not establish that it matches a studied preparation.See reference 2,See reference 7
Study formulations can differ. The 2026 trial used a specified freeze-dried preparation. The studied preparation and follow-up explain the result, while a health professional can assess whether any supplement is suitable for an individual.See reference 4,See reference 7
Who needs particular caution
Hospital reports link this yeast probiotic to fungemia, meaning yeast in the bloodstream. In a five-hospital Finnish study, at least 20 of 46 patients with Saccharomyces fungemia had been using the probiotic. This selected group cannot tell us the chance of infection for an average user.See reference 1
The study authors cautioned against use in patients who were critically ill, had a weakened immune system or had an indwelling catheter. These patients and anyone with complex medical care need advice from their treating team before considering a live yeast supplement.See reference 1
Common questions
Does it work like a bacterial probiotic?
It contains a yeast. Research on one organism or formulation does not automatically apply to another probiotic.See reference 2,See reference 7
Does evidence for fewer loose stools prove prevention of C. difficile infection?
These are different outcomes. Studies need confirmed infection events to answer the second question, and professional recommendations differ.See reference 4,See reference 5,See reference 6
Does a trial settle how much I should take?
A study can describe what a specific group received. A personal decision depends on the product, the reason for use and the person’s medical circumstances.See reference 1,See reference 3,See reference 4
Get the weekly longevity brief
The week's best longevity research in plain English. Free, every Tuesday.
References
- 1. Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements
Emerging Infectious DiseasesObservational study
- 2. Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea: systematic review and meta-analysis
Alimentary Pharmacology & TherapeuticsMeta-analysis
- 3. Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: a randomized trial
Open Forum Infectious DiseasesRandomized trial
- 4. Saccharomyces boulardii for Prevention of Antibiotic-Associated Diarrhea in Hospitalized Patients
AntibioticsRandomized trial
- 5. Role of probiotics in the management of gastrointestinal disorders
American Gastroenterological AssociationGuideline
- 6. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections
American Journal of GastroenterologyGuideline
- 7. Probiotics and Prebiotics
World Gastroenterology OrganisationGuideline
Editorial transparency
- Published by
- LongevityMate Editorial
- Reviewed by
- Editorial evidence review (AI-assisted)
- Published
- Updated
Medical disclaimer
General education. Personal results, diagnoses, treatment and supplement decisions require a qualified health professional.
